Company Filing History:
Years Active: 2015-2019
Title: Birgit Hasse: Innovator in Neuropathic Pain Treatment
Introduction
Birgit Hasse is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of nervous system diseases and disorders. With a total of 3 patents, her work focuses on innovative compounds that target the GABA receptor complex.
Latest Patents
Hasse's latest patents include groundbreaking compounds such as 2-cyano-3-cyclopropyl-3-hydroxy-N-aryl-thioacrylamide derivatives. These compounds are characterized by a complex formula that allows for various substitutions, making them versatile in their application. They are particularly useful in treating diseases responsive to modulation of the GABA receptor complex. Another notable patent involves the use of malononitrilamides in neuropathic pain, providing new pharmaceutical compositions aimed at alleviating neuropathic pain syndromes.
Career Highlights
Birgit Hasse is currently associated with Algiax Pharmaceuticals GmbH, where she continues to develop innovative solutions for pain management. Her work has garnered attention in the pharmaceutical industry, highlighting her role as a key player in advancing treatment options for patients suffering from neuropathic pain.
Collaborations
Hasse collaborates with esteemed colleagues such as Guido Koopmans and Stefan Mullner, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Birgit Hasse's contributions to the field of pharmaceuticals, particularly in the treatment of neuropathic pain, underscore her importance as an inventor. Her innovative patents and ongoing work at Algiax Pharmaceuticals GmbH position her as a leader in her field.